Independent Bank Corp. (MA) (INDB) Jumps 7.3% on January 22

Equities Staff |

Independent Bank Corp. (MA) (INDB) was among the biggest gainers on the Russell 2000 for Friday January 22 as the stock popped 7.3% to $44.37, representing a gain of $3.02 per share. Some 159,900 shares traded hands on 1,990 trades, compared with an average daily volume of 109,535 shares out of a total float of 26.24 million. The stock opened at $48.15 and traded with an intraday range of $48.15 to $43.38.

After today's gains, Independent Bank Corp. (MA) reached a market cap of $1.16 billion. Independent Bank Corp. (MA) has had a trading range between $53.34 and $37.78 over the last year, and it had a 50-day SMA of $47.63 and a 200-day SMA of $45.89.

The stock has a P/E Ratio of 17.1.

Independent Bank Corp is a bank holding company. The Company, through its subsidiary bank, offers banking services, including lending activities, acceptance of demand, savings, and time deposits, and investment management.

Independent Bank Corp. (MA) is based out of Rockland, MA and has some 980 employees. Its CEO is Christopher Oddleifson.

For a complete fundamental analysis analysis of Independent Bank Corp. (MA), check out’s Stock Valuation Analysis report for INDB. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…


Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…